The Paradox of Progress: Why India’s Malaria Success Story Has a Northeastern Blind Spot

When the World Health Organization certified Sri Lanka as malaria-free in 2016, it marked a turning point in South Asia’s battle against the mosquito-borne disease. India, accounting for 83% of all malaria cases in the WHO South-East Asia region as recently as 2017, responded with an aggressive National Framework for Malaria Elimination (2016-2030), targeting zero indigenous cases by 2027 and complete elimination by 2030. The results have been dramatic: from 1.1 million cases in 2015 to just 338,000 in 2023—a 70% reduction in less than a decade.

Yet this national triumph obscures a troubling regional disparity. While states like Odisha (once India’s malaria epicenter) reported a 91% decline in cases between 2017-2023, Northeast India—particularly Manipur—has emerged as the new frontier in the elimination battle. In 2025, Manipur, with merely 0.2% of India’s population, contributed 3.2% of all malaria cases nationally. More alarmingly, Plasmodium falciparum, the deadliest malaria parasite, accounts for 65% of Manipur’s cases—double the national average of 32%. This concentration of severe malaria in a geographically compact region presents both a challenge and an opportunity: could Manipur’s struggle become the testing ground for innovations that finally crack the code on elimination in high-transmission zones?

The Imphal West Experiment: Why This District’s Approach Matters Beyond Manipur

Imphal West, Manipur’s most populous district with 1.7 million residents, has become an unlikely laboratory for malaria elimination strategies. Unlike the forest-fringed tribal districts where malaria has historically thrived, Imphal West’s challenge is urban and peri-urban transmission—a growing concern across South Asia as cities expand into former rural areas. The district’s three-pronged strategy, unveiled during World Malaria Day 2026 observances, isn’t just about local health outcomes; it’s a potential blueprint for other regions grappling with residual transmission in elimination-phase countries.

Vector control in Imphal West has taken a similarly innovative turn. While insecticide-treated nets (ITNs) remain central (with 12,000 households covered in 2025), the district has introduced targeted indoor residual spraying (IRS) using third-generation insecticides like clothianidin, which shows 90% efficacy against resistant mosquito populations. This marks a shift from the blanket IRS approaches of the past, which often faced community resistance and logistical challenges in dense urban areas.

Perhaps most critically, Imphal West is addressing the human dimension of malaria transmission. A 2025 study by the Manipur University Department of Life Sciences found that migrant workers—particularly those in informal sectors like construction and agriculture—were 3.7 times more likely to test positive for malaria than permanent residents. The district’s response? Mobile malaria clinics at major labor gathering points, offering free testing and treatment regardless of residency status. This approach directly challenges the conventional wisdom that malaria elimination must focus solely on endemic populations.

The Bigger Picture: Why Manipur’s Fight Is a Litmus Test for Global Elimination Goals

The stakes in Manipur transcend local public health. India’s malaria elimination timeline is ambitiously aligned with the WHO’s global target of reducing malaria incidence by 90% by 2030. Yet as countries like China (certified malaria-free in 2021) and Malaysia (on track for 2025 elimination) demonstrate, the final push against malaria is often the hardest. The lessons from Manipur could inform strategies in other "hotspot" regions where elimination has stalled, from the Greater Mekong Subregion (facing artemisinin resistance) to sub-Saharan Africa (where cases still exceed 200 million annually).

The Resistance Factor: Why Manipur’s Drug Trials Matter Globally

One of the most concerning developments in Manipur is the emergence of partial resistance to artemisinin-based combination therapies (ACTs), the gold standard for malaria treatment. A 2025 study published in The Lancet Infectious Diseases documented delayed parasite clearance in 12% of P. falciparum cases in Manipur’s Churachandpur district. While not yet at the crisis levels seen in Cambodia (where ACT failure rates exceed 50%), this trend has triggered a collaborative response:

• ICMR’s Regional Medical Research Centre in Dibrugarh is conducting pharmacovigilance studies to track resistance markers.
• Manipur’s health department has introduced triple artemisinin-based combinations (TACs) in high-risk areas, following WHO’s 2024 guidelines.
• A cross-border surveillance network with Myanmar (where ACT resistance is more advanced) aims to prevent resistant strains from spreading.

This proactive stance could position Manipur as a regional sentinel site for drug resistance monitoring—a role with global significance as the malaria parasite continues to evolve.

Climate Change: The Wild Card in Manipur’s Malaria Equation

No discussion of malaria in Northeast India is complete without addressing climate change. The Indian Meteorological Department (IMD) reports that Manipur’s average annual rainfall has increased by 18% since 2000, while temperatures have risen by 1.2°C—creating ideal conditions for mosquito breeding. A 2025 Nature Climate Change study projects that by 2035, Manipur’s malaria transmission season could extend by 4-6 weeks annually due to these shifts.

Imphal West’s response includes:

• Climate-adaptive vector control: Adjusting IRS and larvicide schedules based on two-week weather forecasts from IMD.
• Community-based environmental management: Training local groups to eliminate breeding sites in anticipation of heavy rains.
• Integration with disaster response: Malaria prevention kits (nets, repellents, RDTs) pre-positioned in flood-prone areas.

If successful, this climate-resilient malaria control model could be replicated in other vulnerable regions, from Bangladesh’s coastal districts to Africa’s Sahel.

The Road Ahead: Three Scenarios for Manipur’s Malaria Future

As Imphal West’s initiatives unfold, three potential trajectories emerge—each with distinct implications for India’s elimination goals and global malaria strategy:

Which path Manipur takes will depend on three critical factors:

1. Funding consistency: The National Health Mission allocates ₹30 crore annually for Northeast malaria control—less than 10% of Odisha’s budget despite higher transmission intensity.
2. Cross-border cooperation: Myanmar’s Kayin State, sharing a porous 398-km border with Manipur, reported 14,000 cases in 2025. Coordinated surveillance is essential.
3. Community trust: Historical distrust of government health programs in Manipur (stemming from decades of conflict) requires localized outreach—something Imphal West’s mobile clinics are beginning to address.

Conclusion: Why the World Should Watch Manipur

Manipur’s malaria challenge is a microcosm of the global elimination dilemma: how to sustain progress in the face of biological, environmental, and socioeconomic complexities. Imphal West’s experiments—from urban surveillance to climate-adaptive control—offer more than local solutions; they provide a real-world stress test for elimination strategies in similar high-burden pockets worldwide.

The district’s approach also highlights a critical shift in malaria programming: the move from vertical, disease-specific interventions to integrated, systems-based responses. By embedding malaria control within broader health systems (e.g., linking mobile clinics to primary care networks) and addressing social determinants (e.g., migrant health access), Imphal West is pioneering a model that could redefine how elimination is pursued in the 2030s.

As Dr. Neeraj Dhingra, former director of India’s National Vector Borne Disease Control Programme (NVBD